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ABSTRACT Pharmaceutical solid dosage forms (tablets or
capsules) are the predominant form to administer active phar-
maceutical ingredients (APIs) to the patient. Tablets are typi-
cally powder compacts consisting of several different excipi-
ents in addition to the API. Excipients are added to a formu-
lation in order to achieve the desired fill weight of a dosage
form, to improve the processability or to affect the drug re-
lease behaviour in the body. These complex porous systems
undergo different mechanisms when they come in contact
with physiological fluids. The performance of a drug is pri-
marily influenced by the disintegration and dissolution behav-
iour of the powder compact. The disintegration process is
specifically critical for immediate-release dosage forms. Its
mechanisms and the factors impacting disintegration are
discussed and methods used to study the disintegration in-situ
are presented. This review further summarises mathematical
models used to simulate disintegration phenomena and to
predict drug release kinetics.
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ABBREVIATIONS
∆P Total effective pressure
∆β Pore size distribution
∆δ Swelling
A Material constant (swelling)
a Expansion rate
ACB Alternate current biosusceptometry
API Active pharmaceutical ingredients
C0 Initial stresses of the tablet
CC Convective portion of the disintegration
CCS Croscarmellose sodium
Cd Diffusive portion of the disintegration
cS Concentration of the saturated solution
ct Instantaneous concentration
D Diffusion coefficient
DCP Dibasic calcium phosphate
F Disintegration force
F∞ Maximum disintegration force
FBRM Focused beam reflectance measurements
GI Gastrointestinal
K Permeability
k Constant
L Penetration depth
M∞ Absolute cumulative amount of drug
released at infinite time
MCC Microcrystalline cellulose
MgSt Magnesium stearate
MRI Magnetic resonance imaging
Mt Absolute cumulative amount of drug
released at time t
neff Effective refractive index
NIR Near-infrared
PAT Process Analytical Technology
PP Polacrilin potassium
q Volumetric flux
QbD Quality by Design
Rc Capillary radius
Re Mean effective pore radius
Rh Hydrodynamic radius
S Surface area
SQUID Superconducting quantum interference
devices
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SSG Sodium starch glycolate
Tg Glass transition temperature
THz-TDS Terahertz time-domain spectroscopy
TPI Terahertz pulsed imaging
UV Ultra-violet
V Volume of the dissolution medium
w Amount of water entering the tablet
x API mass fraction
XPVP Crospovidone
XμCT X-ray computed microtomography
γ Surface tension
δ Thickness of the diffusion layer
δ0 Initial tablet thickness
δ∞ Thickness of the tablet after swelling
ε Porosity
η Viscosity
θ Contact angle
τ Tortuosity
INTRODUCTION
Solid dosage forms, such as tablets and capsules, still represent
the most widespread technology to orally administer active
pharmaceutical ingredients (API) to the patient. Within this
group disintegrating tablets constitute by far the bulk of phar-
maceutical products. By choosing suitable chemical and phys-
ical properties tablets can be formulated to either release their
API immediately following oral administration (immediate-
release tablets) or to modify the drug release profile with the
aim to achieve improved therapeutic efficacy, reduced toxic-
ity, and improved patient compliance and convenience (mod-
ified release tablets) [1]. Immediate-release tablets are de-
signed to fully disintegrate and dissolve upon exposure to
physiological fluids within a short period of time (2.5 to
10 min) [2]. Such a fast disintegration is even more important
for orally dispersible tablets, which are designed to disinte-
grate in the mouth in less than a minutes before swallowing
[3]. Such formulations are particularly important where a
rapid onset of action is desired, e.g. for analgesics [4] or to
enable enhanced bioavailability of a poorly soluble drug sub-
stance [5]. In contrast, in modified - release tablets the API
release may be designed to be gradual in order to achieve slow
and sustained dissolution in, or selective absorption across, the
gastrointestinal (GI) tract, and/or resulting in a delayed onset
time. Such modification of the drug release can be achieved
either by embedding the API in a polymer matrix that dis-
solves or swells at a slower rate than the drug or by means of a
suitable polymer coating that acts as a mass transfer limiting
barrier [1]. It is common practice to estimate the in-vivo per-
formance of a drug product on its in-vitro drug release profile
by establishing empirical in-vivo in-vitro correlations during the
pharmaceutical product development. However, such
empirical dissolution models have a number of inherent draw-
backs [6, 7], including that i) the elucidation of the underlying
mass transport mechanisms is not possible; ii) not a single
characteristic parameter of the dosage form is related to the
intrinsic dissolution rate of the drug; and iii) the generality of
such empirical models is limited. Therefore, these studies do
result in incomplete process and product understanding.
In the majority of cases, the therapeutic dose of a drug is
relatively small and therefore the API has to be mixed with
suitable excipients to achieve a desired fill volume that allows
for compression of the powder mixture into a suitably sized
tablet. Properties of the API, such as small particle size [8, 9]
and needle-like morphology [10, 11] can lead to processing
limitations such as poor flowability [12], difficulties with
blending [9] as well as undesirable adhesion [13] to surfaces
such as tablet punches or feeder walls [14]. These issues are
addressed by selecting an appropriate processing route and/
or by adding agents like glidants, lubricants or surfactants
[15–18]. The admixture of such excipients is essential to pro-
cess most APIs and to assure a high product quality [19].
However, embedding the drug in a complex matrix typically
reduces its bioavailability, and, in the case of immediate-
release tablets, it commonly delays the onset of dissolution.
Disintegration agents are therefore added to the formulation,
which promote the break up of the tablets into small granules
and their constituent particles and thus enable a faster libera-
tion of the drug particles from the tablet matrix leading to an
increase in surface area for subsequent dissolution. The most
widely used disintegrants are synthetic polymers such as
crospovidone (XPVP), croscarmellose sodium (CCS) and so-
dium starch glycolate (SSG) [5, 20–22]. Given that in
immediate-release tablets disintegration is a necessary require-
ment for dissolution, the disintegration performance has a
direct impact on the therapeutic effect of the medication and
must be assessed, and ideally quantified, using specifically de-
signed disintegration tests.
The disintegration process is an integral step in ensuring,
and indeed maximising, the bioavailability of the API from
the majority of solid dosage forms. With the exception of
diffusion - controlled matrix systems, in tablets the wetting
and subsequent disintegration of the powder compact is the
first step towards the liberation of the API from the dosage
form. Without disintegration only the API near the surface of
the tablet would be able to dissolve and hence the reproduc-
ible and full disintegration of the tablet upon exposure to the
dissolution medium is of critical importance to achieve a reli-
able clinical performance of the dosage form (Fig. 1).
Given the central role of the disintegration process for the
therapeutic success of the dosage form it is somewhat surpris-
ing that the mechanistic understanding of this process has not
received more attention over the past 50 years. In our view
this lack of understanding can be explained by a combination
of the complexity of the disintegration process paired with the
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absence of quantitative measurement techniques to accurately
describe the disintegration process in sufficient detail.
Compared to other scientific disciplines that deal with similar
processes the mechanistic understanding of pharmaceutical
disintegration poses a range of significant problems: i) There
is an enormous variety of disintegrating matrices of interest.
Essentially each tablet formulation is unique from a chemical
point of view given the vast range of API properties and the
wide range of excipients that are in common use. ii) Some
formulations contain excipients that swell significantly over
time with exposure to the dissolution medium, resulting in
strongly non-linear time and temperature dependence of the
swelling process. iii) The process route (direct compaction, dry
or wet granulation, compaction conditions) has a significant
impact on the tablet microstructure and changes in these pa-
rameters are common during the pharmaceutical develop-
ment process. In many cases the final microstructure of the
dosage form is only defined by the production scale process
development just before the product is produced commercial-
ly and where no significant changes in formulation are possi-
ble any longer given the regulatory filing requirements and the
pressure to minimise the time to market. iv) Changes in the
physical properties of the supplied excipient have traditionally
not been as tightly controlled compared to the chemical qual-
ity and impurity profiles. In addition, different batches of API
can exhibit changes in particle size and morphology. v) Prior
to the quality by design (QbD) initiatives changes to the pro-
cess parameters during commercial production of a marketed
product were extremely costly and hence a better understand-
ing of the microstructure of the dosage form was not of much
commercial advantage to the industry as batches that failed
disintegration were likely to be discarded.
Against the background of such formidable challenges it is
easy to understand that for a long time there was little moti-
vation to understand the complex physics of tablet disintegra-
tion from a commercial perspective. It is well understood that
the drug release kinetics is a, if not the, critical link between the
solid dosage form and the API plasma concentration. Given
there are numerous sophisticated highly accurate methods
available to quantify the amount of API released form a dos-
age form over time during in-vitro dissolution tests it makes
perfect sense that the detailed understanding of the dissolution
process and the field of in-vitro in - vivo correlations has
attracted such strong interest. The need to develop a sound
understanding of dissolution also explains why there has been
relatively little activity in advancing the detailed insight into
the disintegration process. However, in this context it is also
crucial to highlight the lack of suitable analytical technologies
to reliably identify, measure and quantify the complex mass
transport processes andmechanical changes in a tablet sample
during disintegration. In the absence of such measurement
technologies it is clearly not possible to develop accurate
mechanistic models – and it is only through the understanding
of the disintegration process that it is possible to fully quanti-
tatively describe the dissolution of API as it is necessarily the
first step of drug release from a disintegrating matrix (Fig. 1).
Fig. 1 Schematic of the drug
release process from a tablet
(modified from [207]).
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Whilst the assumption of rapid and full disintegration might
be justified in the majority of cases there is sufficient anecdotal
evidence that a substantial amount of batch failures in
immediate-release dosage forms have their root cause in poor,
and unexplained, disintegration behaviour.
The first official disintegration test was published in the
Swiss pharmacopeia in 1934 [23]. The method specified that
a tablet has to be placed in a 100 mL conical container, then
50mL of water at 37 ° C was added, and upon exposure of the
tablet to water the container was shaken periodically. The
disintegration time had to be 15 min or less. Over the years
a number of different methods were developed that were
based on the same concept but saw some variation in terms
of the mechanics of the testing instrument by using tubes [24],
a rolling drum [25] or meshes [26]. In addition, there were
variations in terms of the disintegration liquid by introducing
simulated gastric juice [27] to better mimic the actions in the
body on the tablet [28]. Filleborn developed an artificial stom-
ach by simulating the pH, presence of food, peristalsis, volume
of gastric juice and hydrostatic pressure, and emphasised that
simple in-vitro disintegration tests are valuable only if they can
simulate the in-vivo conditions [29]. However, the disintegra-
tion test that is required today by the respective
pharmacopoeiae [30–32] does not differ significantly in terms
of the measurement concept developed for the very first test
that was introduced in 1934: a tablet is placed within an open
ended tube on a wire mesh that is fitted at one of its ends. The
tube with the tablet is then mounted such that it can be peri-
odically moved up and down in a 1 L beaker of water, simu-
lated gastric juice or simulated intestinal fluid at 37 ± 2 ° C for
a predetermined time. After the exposure period the tube is
checked for the presence of the sample specimen. If a palpable
core is still present the test is considered to have failed. This
type of test was reviewed in detail by Donauer and Löbenberg
[33].Whilst the test is overall suited to establish whether or not
a tablet fully disintegrates within a given exposure period, or
how much time is required to disintegrate a tablet, such tra-
ditional disintegration testing does not provide any insight into
the mechanism of tablet disintegration. The results of the dis-
integration test are used nonetheless to assess whether the
dosage form meets the requirements of the respective phar-
macopoeia even though it yields little fundamental informa-
tion about the drug release behaviour of the dosage form. As
outlined above, a detailed understanding of the underlying
disintegrationmechanisms which occur when the tablet comes
in contact with the physiological fluid is highly desirable. Such
understanding requires the development of mechanistic
models which describe the fundamental mechanisms based
on quantitative disintegration and dissolution data.
Significant advances in analytical techniques over the past
years enabled the quantitative investigation of changes in the
microstructure during the disintegration of a pharmaceutical
tablet. Experimental data from such analytical techniques is
the basis for a comprehensive understanding of the function-
ality of the excipients and the API as well as their influence on
the disintegration and dissolution process. The aim of this
review is to provide an overview of the mechanism of disinte-
gration, to present different methods used for in-situ monitor-
ing of the microstructural changes of pharmaceutical powder
compacts, and to summarise the existing models used for de-
scribing the different disintegration phenomena.
MECHANISM OF TABLET DISINTEGRATION
Disintegration refers to the mechanical break up of a com-
pressed tablet into small granules upon ingestion and there-
fore it is characterised by the breakdown of the
interparticulate bonds, which were forged during the compac-
tion of the tablet. It is hence a good starting point to briefly
reflect on the physical changes that take place during the com-
paction process: i) particle rearrangement, ii) elastic deforma-
tion, iii) plastic deformation, and iv) fragmentation of particles,
as well as v) the formation of interparticulate bonds [34]. Steps
ii) to v) may have a direct influence on the disintegration of the
powder compact. The reduction of the compact volume is
performed by the reversible elastic or by the irreversible plastic
deformation. After an initial volume reduction the particles
can be divided-up into smaller particles, a process that is also
called fragmentation. These smaller particles may then under-
go further elastic and/or plastic deformation. When the par-
ticles come into close proximity to each other they can form
interparticulate attraction bonds, such as intermolecular
bonds, solid bridges and mechanical interlocking (Fig. 2)
[34]. Naturally, the bonding surface area limits the maximum
tensile strength that can be achieved for the powder compact.
Intermolecular bonds in general, and van der Waals forces in
particular, dominate the cohesive characteristics of many di-
rect compression binders, such as microcrystalline cellulose
(MCC, Avicel®) and lactose. Solid bridges are defined as
the contact at an atomic level between adjacent surfaces of
particles and thus, these forces act up to a distance of 1 nm.
Mechanical interlocking is the hooking and twisting together
of packed particles. A high compaction load is required to
generate mechanical interlocking and this bonding mecha-
nism depends on the shape and surface structure of the parti-
cles, i.e. long needles and irregular particles have a higher
tendency to hook and twist together during compaction com-
pared to smooth spherical particles [34]. Nyström et al. [34]
and Adolfsson et al. [35] showed on the basis of the tensile
strength of tablets that the bonding structure and the bonding
mechanisms depend on the chemical structure, volume reduc-
tion behaviour (i.e. elastic deformation, plastic deformation
and particle fragmentation) and particle size. Furthermore,
during disintegration the liquid penetrating the powder builds
capillary bridges, which cause an attractive force of adjacent
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particles. A force has to be generated during disintegration
which surpasses the interparticulate forces and disrupts the
bonds. The actual bonding mechanisms and bonding surface
area thus have a direct impact on the disintegration process.
The first and often the rate-determining step in disintegra-
tion is the liquid penetration in the porous powder compact
[36]. Liquid penetration does not directly build up the pres-
sure which is necessary to rupture the particle-particle bonds,
but it is a prerequisite to initiate other mechanisms like swell-
ing (see Fig. 3).
Swelling is one of the most accepted mechanisms involved
in disintegration [37–39]. The swelling is the omni-directional
enlargement of particles, which build up pressure, push apart
adjoining particles, leads to exertion of stresses on the overall
systems and finally breaks up the tablet [21]. The dissolution
fluid in itself exerts a force in the tablet pores, but this force
alone can be too low to be effective, particularly if the bonds
between the solid particles are strong. In the presence of a
disintegrant, however, the forces exerted by the fluid become
appreciable enough to destroy the compact [40].
Another well-known disintegration mechanism is strain re-
covery. The strain within the tablet is the consequence of
forcing macromolecules into a metastable configuration either
due to interlocking of the polymer chains or as a result of
spontaneous crystallisation during the compaction of a tablet.
The stored energy can be released as heat immediately fol-
lowing the compaction or, if this is not or only partially the
case, when the polymer comes in contact with a fluid, i.e.
disintegration medium or physiological fluids. Hydration of
the polymer gives rise to sufficient mobility for entropy recov-
ery to take place, and, with that, recovery of the original shape
of the polymer molecules [22, 41]. Therefore, strain recovery
can be regarded as the reversible viscoelastic process of defor-
mation [42]. It is uni-directional and in the opposite direction
of the applied compression force (see Fig. 3). Recently, Desai
et al. [43] andQuodbach et al. [44] investigated strain recovery
in more detail and they concluded that one of the disintegra-
tion mechanisms of tablets containing XPVP is due to strain
recovery.
Moreover, hydration, swelling and strain recovery of many
hydrophilic polymers in water changes the mechanical prop-
erties of these materials from dry solids to soft and rubbery
states. The sorption of water results in a lowered glass transi-
tion temperature (Tg) of the polymer, which may impact the
swelling or strain recovery kinetics. Schott [45, 46] revealed
that the kinetics change from first-order to second-order swell-
ing kinetics as the Tg is crossed during swelling and hydration
and that an equilibrium is reached when the swelling pressure
equals the elastic recovery of the swollen network. In the pres-
ence of the strong dipole and high mobility of water molecules
interchain macromolecular hydrogen bonds can break, which
reduces the interchain attraction and further plasticise the
amorphous portion of the polymer. This allows additional
chain segments to slip past one another and weaker the cohe-
sive energy between the chain segments of the structure to
absorb more fluid. In contrast, the more dense crystalline re-
gions of the polymer contribute far less to swelling as they are
less accessible by the water molecules and the cohesive forces
between chain segments is higher compared to the amorphous
domains. High degrees of crystallinity of such swelling poly-
mers can thus slow down or even prevent disintegration [46].
Independent of whether the volume enlargement of the
polymer powder particles is caused by strain recovery, swell-
ing or a combination thereof the strain that develops within
the porous tablet matrix is released through the growth of
defects into micro-cracks, which in turn increases the (easily
accessible) pore space in which water can enter. This process
accelerates tablet hydration and, in turn, disintegration.
In addition, the fluid can dissolve or dislodge excipient
particles from pore walls, which can significantly affect the
porosity and as a result the disintegration performance [22,
Fig. 2 Overview of particle bonds. The bonding surface areas are highlighted
in red.
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47, 48]. Not surprisingly this effect is especially significant for
powder compacts incorporating soluble components [22, 49].
As a result the viscosity of the liquid phase and the structure of
the porous system can change drastically with time; both ef-
fects would impact liquid penetration [50]. Shah and
Augsburger [51] investigated the effect of physical differences
on the disintegration and dissolution for a disintegrant
(XPVP) from different sources embedded in either a soluble
or insoluble matrix. They concluded that there is a direct
effect of the physical properties of XPVP (including particle
size and distribution, surface area, porosity and surface mor-
phology) on the disintegration time and dissolution rate when
used in a formulation that was based on an insoluble filler.
Even though overall a faster disintegration could be achieved
for a formulation using a soluble filler compared to a tablet
with an insoluble filler, differences in physical properties of
XPVP did not affect the disintegration time. The effect of
the solubility of the filler is intuitive in that the filler is typically
present at relatively large concentration and so long the disso-
lution rate of the filler is reasonably high the liquid can easily
penetrate into the soluble matrix and hence disintegrate the
tablet.
It has further been proposed that exothermic (heat gener-
ation) and endothermic (heat absorption) processes can cause,
or at least facilitate, the break up of the powder compacts [47,
52]. Specifically, it was hypothesised that the generation of
heat may cause localised stress due to the expansion of air
retained in the powder compact leading to the break up of the
inter-particle bonds. It is important to note in this context that
the papers by Matsumaru were published in Japanese and
hence potentially hard to retrieve from the U.S.A. at the time
as evidenced by the fact that Loewenthal cites the Chemical
Abstracts service in addition to the original citation in his
review. The papers are now readily accessible and closer read-
ing of the work reveals that Matsumaru did not claim that the
heat of interaction is a fundamental disintegration mechanism
but rather he provided calorimetric data to show that there
can be measurable heat upon disintegration [52–58]. The
results are in good agreement with the discussion of entropy
recovery above. Besides this potential misunderstanding of the
literature it is questionable from a physical point of view if the
pressure built up in residual air by the change in temperature
from such localised stress could ever initiate tablet disintegra-
tion. If this would be a significant mechanism, then the heat
generated during compression and ejection of the tablet
would already disrupt particle-particle bonds, which would
lead to the break up of the tablet immediately after compac-
tion [21, 47]. In the light of the limited experimental evidence
that has been presented for this hypothesis by just a single
research group in the late 1950s and the relatively modest
Fig. 3 Overview of mechanisms involved in disintegration of pharmaceutical powder compacts.
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amount of stored energy, that furthermore would need to be
released instantaneously to result in any appreciable pressure
build up, this mechanism of disintegration should no longer be
considered.
More information about the actions of various
disintegrants and their mechanisms can be found in several
other recent review articles [21, 22, 47].
FACTORS AFFECTING LIQUID PENETRATION
Disintegration is achieved by the penetration of the physiolog-
ical fluid into the powder compact and the subsequent disrup-
tion of the particle-particle bonds which maintain the struc-
tural integrity of the dosage form. Therefore, liquid penetra-
tion (or wicking) is one of the key steps involved in the disin-
tegration process. The rate of penetration of liquid into a
porous matrix is driven by the interplay between the capillary
forces that promote fluid movement towards the interior and
the viscous forces that oppose the liquid movement. Liquid
retention and flow in unsaturated porous media, where the
pores are filled with both liquid and air, are thus driven by the
balance between cohesion among the liquid molecules and
adhesion between the liquid molecules and the particle sur-
faces [59].
Therefore, the wicking process in immediate-release tablets
is assumed to be driven by capillary action, as it was already
suggested in 1955 by Curlin [60] for aspirin tablets. Capillary
action is a well studied phenomenon due to its numerous
applications, such as in petroleum engineering, in hydrology
(e.g., movement of ground water), in consumer products (e.g.,
marker pens, candle wicks and sponges) or in plants (e.g., trans-
port of water from the roots to the tips). Mathematical models
have been well established for some time to describe the vol-
umetric flux in a porous medium. By combining the Hagen-
Poisseuille (Eq. 15) and the Young-Laplace (Eq. 16) equations,
two such expressions that arewell known in fluid dynamics, the
following expression for the volumetric flux q of the fluid as a
function of the penetration depth, L, can be derived (see
Appendix A for the derivation):
The dependence of the liquid penetration on the physical
properties of the matrix, fluid and fluid/matrix can readily be
recognised in the mathematical representation of the volumet-
ric flux (Fig. 4). The relevant fluid properties are surface ten-
sion, γ, and viscosity, η. The contact angle, θ (wettability), is a
fluid/matrix property and the relevant solid matrix properties
are pore size distribution, Δβ, and tortuosity, τ. Rh,0 is the
hydrodynamic radius and Rc,0 is the capillary radius, which
is seen by the liquid meniscus. The capillary force remains
reasonably constant, whereas the viscous forces increase with
penetration causing a decrease in the overall penetration rate
as saturation proceeds. However, the viscous forces along the
disrupted pore system may drop due to a disruption of the
particles and this in turn can lead to an increase in penetration
rate. At the same time, the capillary forces may remain un-
changed as the curvature of the meniscus of the advancing
liquid front is governed by the dry, undisrupted, pore system
[61]. In contrast, the capillary force is influenced by the hy-
drophilicity (related to the contact angle) of the excipients,
discussed by Guyot-Hermann and Ringard [62]. Here the
importance of sufficiently well distributed hydrophilic excipi-
ents in a tablet was emphasised. Such excipients can convey
liquid from the surface to the centre to accelerate disintegra-
tion. Although the physical properties of the fluid and the pore
structure influences both capillary and viscous forces, once the
excipients are selected tablet formulators can only control the
pore structure as the physical properties of disintegration liq-
uid are typically not free variables (even though different dis-
solution media certainly will exhibit a range of viscosities and
wetting behaviours).
In pharmaceutical practice the pore structure is often
only described by the total porosity, which is the fraction
of the volume of voids over the total volume and thus it is
a measure for the void space in the material. It was shown
that the tablet porosity is one of the most important contrib-
utors to the disintegration performance [63] and that it
highly depends on the compaction force and compression
speed [10, 36, 64–67]. In general, small pores decrease the
ability of a fluid to enter the powder compact, whereas a
high porosity, associated to a large void space, may lower
the force induced by the swelling of excipients. Therefore, a
lower swelling force increases the time to break up inter-par-
ticle bonds [47, 68]. However, the complex pore structure
cannot by adequately represented by one single parameter
such as the total porosity. Porous media can be more accu-
rately described by a combination of parameters such as
characteristic length (effective pore radius in the porous me-
dium), a constriction factor (fluctuation in local hydrody-
namic radii), a tortuosity (effective length of the streamlines)
and an effective porosity (the ratio of the volume of the
conducting pores to the total volume). The characteristic
length, tortuosity and constriction factor are direction de-
pendent descriptors of the pore structure, and an anisotropic
permeability behaviour of powder compacts is not uncom-
mon [69–72]. In line with such behaviour it was shown in a
number of studies that the density of tablet matrices is often
unevenly distributed (i.e. density increases with radius for
standard biconvex tablets) [73–75].
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These key characteristics that describe the pore network struc-
ture can often be extracted sufficiently well from high-
r e so lu t i on th ree -d imens iona l X- ray computed
microtomography (XμCT) images of porous media [76, 77],
although the detectable pore sizes are often limited by the pixel
size of the image and samples have to be taken from the dosage
form to achieve the highest resolution (> 0.5 μm for the most
commonly used commercial bench-top instruments) [78]. In ad-
dition, traditional porosimetry techniques can be employed to
measure the porosity directly using liquid or gas intrusion [79,
80]. An alternative approach to rapidly and non-invasively mea-
sure the bulk porosity of whole tablets was recently demonstrated
by Bawuah et al. [81] using terahertz time-domain spectroscopy
(THz-TDS) [82, 83]. The analysis of porosity from terahertz
measurements is based on its relation to the effective refractive
index of the probed tablet (Fig. 5). The method was demonstrat-
ed by measuring the porosity of thin flat faced tablets [81] con-
taining pure MCC as well as flat faced tablets made of MCC
and an API [84]. This was further developed to analyse thicker
biconvex tablets [85], which led to the analyses of immediate-
release tables consisting of a complex formulation [86]. This
study is discussed at the end of this section (Fig. 5).
Besides the pore structure itself further factors need to be
taken into account when considering the liquid penetration into
a porous medium. The capability of a porous medium to trans-
mit fluid is typically summarised by its permeability, K (as de-
fined in Darcy’s law [87]), which is therefore a fundamental
attribute of the performance of the disintegrating tablets. The
permeability is however closely tied to the pore structure of the
powder compact (the derivation is given in Appendix B):
K ¼
1
8τ
XM
j¼1
Δβ jR
2
h; j : ð2Þ
One of the first experimental approaches to measure air
permeability of a tablet (Fig. 6) was presented by Lowenthal
and Burrus [88]. The system consisted of a vacuum rig with
the tablet sealed into a rubber stopper that separated the
vacuum from the atmosphere. The rate of air permeating
through the tablet was measured by the amount of water that
was displaced in the connected impinger over time whilst also
recording the pressure drop. The authors then calculated the
mean pore diameter from the air permeability measurement
using the Kozeny-Carman equation. A similar procedure was
presented by Alderborn, Duberg and Nyström [89] to deter-
mine the specific surface area of pharmaceutical tablets from
air permeability measurements. However, these measure-
ments provide an accurate measurement for the permeability
with air and it is not trivial to extend the method to measure
liquid penetration into the powder compact due to the com-
plex interplay between liquid penetration kinetics, swelling
and dissolution, which result in a time- and spatially-
dependent permeability.
The interdependence between permeability of a tablet and
its pore structure, and thus porosity, was studied by
Ganderton and Fraser [61] for different formulations ranging
from aspirin, lactose, magnesium carbonate, calcium phos-
phate to phenindione and sucrose tablets. They emphasised
the impact of tablet compaction pressure, particle size and
granulation on the porosity and permeability. In particular,
they reported that almost impermeable structures were
formed from fine particles of aspirin and phenindione which
resulted in the lowest water penetration rate. In contrast, for-
mulations containing lactose resulted in the most permeable
tablets and yielded the fastest liquid penetration.
As already mentioned above, the fluid composition can
significantly influence the disintegration of powder compacts
[90]. Biorelevant media considerably differ in viscosity, con-
tact angle and surface tension and hence the liquid penetra-
tion kinetics is affected by the choice of medium [91]. The
majority of studies focused on using water as the disintegration
medium and thus may lack physiological relevance as most of
Fig. 4 Impact of porous medium properties, fluid properties, processing parameters and routes as well as raw material properties on wicking. The arrows and
shaded areas highlight the influence of processing and raw material related properties on wicking.
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the tablets are designed to disintegrate in the gastric juice and
not in water. This was already highlighted by Abbott et al. in
1959 [92], where the authors compared the disintegration of
commercial tablets in simulated gastric juice with the same
experiment carried out with pooled human gastric juice.
The in-vitro disintegration was prolonged in human gastric
juice and Abbott et al. assumed that this was due to a change
of the liquid properties: a higher viscosity of the medium leads
to a slower disintegration and a lower surface tension of the
medium results in more rapid disintegration [36, 92, 93]. A
more viscous fluid may promote adhesion between larger par-
ticles, and thus counteract the swelling mechanism of
disintegrants. Moreover,depending on the temperature some
disintegrants are known to form a gel when they become hy-
drated (i.e. in CCS an increase in temperature promotes hy-
drogel formation) [94–96]. Any gel phase is formed in situ and
will directly fill the macropores of the disintegrating matrix
and thus slows down the liquid penetration.
Whilst the performance of a tablet is strongly influenced by
the rawmaterial properties [97] it is important to highlight the
significant impact of the processing route and the processing
parameters on the dosage from microstructure, and in turn
the disintegration behaviour [14, 98].Markl et al. [86] recently
presented results of a study of immediate-release tablets where
the impact of changes in process parameters on the disinte-
gration and dissolution performance was analysed in detail
(Fig. 7). The tablets were produced by a high-shear wet gran-
ulation process, fluid-bed drying and subsequent compaction.
The pore structure of the tablets was analysed by THz-TDS.
Since the formulation was the same for all batches, the varia-
tions in disintegration (disintegration time ranges from 280 s
to 900 s) and dissolution (API dissolved after 15 min ranges
from 35% to 85%) performance originated solely from the
microstructure of the tablets. In this study the disintegrant
was incorporated in the matrix intra- and inter-granularly. It
is well know that the mode of consolidation of the excipients
and the API, namely intra-, inter-granularly or in both phases,
can impact the disintegration behaviour of a tablet [61,
99–105]. Therefore, the effectiveness of an excipient and es-
pecially of a disintegrant in different modes of incorporation
can be significantly affected by the granulation technique and
its configuration.
QUANTIFYING DISINTEGRATION
MECHANISMS
Most quantitative studies to date have either focused on mea-
suring the swelling of single particles that are used as pharma-
ceutical excipients or on measuring the increase in volume of
the entire dosage form during disintegration. For example
Rudnic et al. [106] observed wetting and swelling of individual
disintegrant particles using a microscope. They found that the
rate and extent of swelling for any given type of disintegrant
varied with particle size, i.e. larger particles showed substan-
tially greater rates and extent of swelling compared to smaller
particles. However, the contribution of the disintegrant parti-
cle size to total disintegrant action was found to depend on the
particle size distribution (polydisperse vs monodisperse) of all
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Fig. 5 Method to determine the porosity of a flat faced tablet by THz-TDS.
Tablets of MCC and indomethacin were varied either in porosity ε, height, or
API mass fraction x as specified in the legend. (a) Schematic of the terahertz
transmission measurement to measure the effective refractive index, neff, of a
tablet. (b,c) Effective refractive index measured by THz-TDS as a function of
the porosity of a tablet. The porosity was calculated from the relative and
apparent densities of the sample. The API mass fraction in (a) was kept
constant at 10 wt% (modified from [84]).
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excipient(s) and API(s) [107]. In a polydisperse formulation,
small particles can fit within the pores between large ones and
thus hinder the liquid from penetrating the powder compact
and resulting in increased disintegration time. Formulations
based on polydisperse particles furthermore increase the
interparticulate bonding surface area (Fig. 2) which results in
an increased tensile strength and thus may prolong the disin-
tegration of such powder compacts. Clear understanding of
tablet disintegration mechanisms can only be developed by
investigating the entire powder compact and considering its
formulation alongside its microstructural properties.
Several studies were performed to measure water uptake
into powder beds based on the apparatus presented by
Nogami et al. [108] (Fig. 8). The water uptake of the powder
bed was measured volumetrically by a graduated pipette and
the swelling was recorded by reading the changes on the grad-
uated glass tube. The same group also investigated the pene-
tration rate of water into a powder bed. A certain amount of
powder was packed in a graduated tube, which was then im-
mersed in a thermally controlled beaker. The penetration
front of the water into the packed powder was recorded and
analysed on the basis of the Washburn equation.
Gissinger and Stamm [109] used the device shown in Fig. 8
to investigate the dependence of the water uptake on the wet-
tability of a broad range of disintegrants. They emphasised
that disintegration is accelerated for materials that exhibit a
small contact angle, which is also in agreement with Eq. 1
indicating that a smaller contact angle leads to a larger volu-
metric flux. They further measured the swelling of tablets of
pure disintegrants during the water uptake measurement
using a linear inductive transducer. The authors concluded
that an investigation of the disintegration action has to con-
sider wettability (contact angle), water absorption and swelling
capability of the powder compact.
A systematical characterisation of various formulations in-
cluding different disintegrants and also for different micro-
structural properties was conducted in the 1980s on the basis
of analysing the disintegration force (in the literature also
known as the swelling force) as a function of time. For exam-
ple, Colombo et al. [110] studied the effect of model substance
properties, the properties and quantity of disintegrant, viscos-
ity and temperature of the solvent and compression force on
the disintegration force-time measurements. The authors in-
dicated that the higher the model substance hydrophilicity,
the lower the expansion rate constant and thus it was conclud-
ed that the diffusion process slows down the tablet expansion
process. Moreover, it was found that the expansion rate con-
stant decreases with increasing viscosity of the solvent and with
increasing compression force (i.e., reduction of the tablet po-
rosity) and thus both cases prolong the disintegration time.
Various other methods [40, 111–114] have been developed
to study the mechanical force-time curves during
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Fig. 6 Air permeability apparatus
from Lowenthal and Burrus [88].
The impinger beaker was filled with
freshly boiled, cooled water. The
tablet was sealed to the rubber
stopper and the 3-way stop cock
were opened prior to the
measurement.
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disintegration by recording the swelling force exerted by the
tablet against a fixed barrier. These measurements were then
related to the structure of the tablet. Some of the studies [115,
116] analysed the data on the basis of a Weibull distribution,
which was introduced to the pharmaceutical community by
Langenbucher [117] to linearise dissolution curves. The
Weibull distribution was found empirically to analyse most
common dissolution data by a few characteristic parameters.
The distribution can be expressed as
log −ln 1−
F
F∞
  
¼ blog t−t0ð Þ−log a: ð3Þ
F is the disintegration force at time t and F∞ is the maxi-
mum disintegration force. The parameters a, b and t0 were
estimated from the best fit of the experimental data.
Furthermore, replacing the parameter a= (τd)
b provides the
more informative parameter τd, which represents the time
needed to obtain 63.2% of the maximum disintegration force
(measured from the end of the lag time t0). Colombo et al.
[115] introduced an input value, i.e. the disintegration force
development rate at time t= t0+ τd, which is very sensitive to
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Fig. 8 Apparatus to measure water uptake and swelling of a powder bed
(modified from [108]).
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the formulation and structural changes of the tablet. They
further revealed a good correlation between the input value
and disintegration time.
Since liquid penetration, swelling and dissolution influence
each other, it is necessary to measure and quantify each aspect
individually in order to gain insights into their complex inter-
play. Dees [118] developed an apparatus to determine water
penetration, water up-take and swelling simultaneously
(Fig. 9). The measurement was started by removing the metal
foil between the glass filter and the dry tablet sample resulting
in the wetting of the tablet. The amount of water absorbed by
the tablet can be measured by the microbalance. The swelling
of the tablet is recorded by the inductive displacement trans-
ducer. The apparatus is also equipped with humidity sensors
to detect the time when the water reaches the upper tablet
face. The penetration depth was calculated from the swelling
by assuming that the water moves throughout the tablet as a
horizontal front and that the effectiveness of swelling is con-
stant across the entire tablet.
Catellani et al. [112] measured simultaneously the amount of
water absorbed and the force developed by the same tablet
during its disintegration (Fig. 10). The principle for determining
the amount of absorbed water is based on measuring the mass
of fluid displaced by the tablet which corresponds to the upward
thrust caused by a body immersed in a fluid. The tablet is
pressed against the glass disk of the cage where the punch linked
to the extensimetric loading cell which allows the measurement
of the swelling force. The same device design was used to study
the effect of pH and ionic content [119, 120] and to analyse the
shapes of the disintegrating force versus time curves. The shapes
of the force versus time ranged from a skewed distribution curve
to a bell-shaped curve, depending on whether slow or rapid
disintegration of tablets dominated, respectively. In order to
compare different disintegrants, Caramella et al. [121] com-
bined the disintegration force and water uptake measurements
to one single parameter, i.e. force-equivalent parameter. This
parameter expresses the maximum capability of a swelling
agent to transform water into a force and it was used to char-
acterise the efficiency of disintegrant swelling. Bell and Peppas
[122] developed another apparatus to investigate the swelling
behaviour of crosslinked hydrophilic polymers under an ap-
plied load as a function of time and absorbed weight. The
results indicated that the swelling capacity is a function of the
polymers’ degree of crosslinking.
Using the swelling force and water uptake measurements, it
was possible to relate different disintegrants to specific disinte-
gration mechanisms, i.e. swelling mechanism for SSG and
CCS, and the strain recovery mechanism for XPVP [113].
These findings were supported by a study from Desai et al.
[43], who applied high-speed video imaging to visualise the
disintegration and wetting of free disintegrant particles and
compacts. They concluded that there was no significant swell-
ing associated with XPVP in free and compacted particles.
However, the effect of compression force on the disintegration
of compacts containing XPVP strongly indicated that strain
recovery is the major mechanism for XPVP disintegrant ac-
tion. It was further shown on the basis of force and water
uptake measurements that disintegration times of tablets with
a swelling disintegrant are only slightly affected by relative
tablet density, whereas the strain recovery disintegrant re-
quires high relative densities for rapid disintegration [123].
The water uptake rate is in particular influenced by the per-
meability of the powder compact as discussed in the previous
section.
In order to simultaneously study the penetration of liq-
uid, microstructural changes and swelling, one needs to
adequately visualise the process of disintegration from with-
in a tablet in a non-destructive and contactless manner.
Magnetic resonance imaging (MRI) was used very success-
fully to generate cross-sectional images of modified-release
tablets during the exposure to liquid [124–127] and thus it
was primarily used to study slow mass transport and swell-
ing kinetics over a time scale of hours. However, Tritt-Gloc
and Kowalczuk [128] employed dynamic MRI to study the
disintegration behaviour of paracetamol tablets in-vitro un-
der acidic gastric pH conditions. They employed an MRI
system with an in-plane resolution of 117 × 117 μm2 and a
section thickness of 200 μm. The authors estimated disinte-
gration profiles on the basis of the MRI images for different
commercial tablets containing paracetamol and for different
fluid temperatures. Recent advances in high-resolution real-
time MRI [129, 130] enabled the recording of MRI videos
of disintegrating tablets (Fig. 11a) with a temporal resolu-
tion of 75 ms, a spatial resolution of 80 × 80 μm2 and a
section thickness of 600 μm as presented by Quodbach
et al. [44]. The improvements in terms of acquisition speed
and resolution enabled a more detailed analysis compared
to the setup presented by Tritt-Gloc and Kowalczuk [128].
The quantitative evaluation of the MRI data was per-
formed on the basis of the grey value distribution of each
image yielding information about the distribution and rela-
tive amount of water within a tablet during disintegration.
This analysis was applied to differentiate the disintegration
action of different disintegrants, where the results indicated
differences between SSG (swelling), CCS (swelling),
polacrilin potassium (PP, swelling) and XPVP (strain recov-
ery) disintegrants [44]. The same group also presented an
alternative data processing method of the MRI data [131],
which calculates fractal dimensions of tablet boundaries
(Fig. 11b and c). The fractal dimension is directly related
to the surface area of a tablet and thus provides informa-
tion about the effectiveness of the disintegration. However,
this method could not sufficiently differentiate between tab-
lets of varying relative densities and it only covers the initial
phase rather than the complete course of the disintegration
process.
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Relative density differences and elastic properties of tablets
can be studied by means of non-destructive ultrasonic mea-
surements [132]. Akseli et al. published several articles about
the use of ultrasonic methods to analyse mechanical properties
of tablets [133, 134] and recently they utilised ultrasonic mea-
surements to predict the breaking force and disintegration
time of tablets [135]. The authors applied machine learning
concepts (neural networks, genetic algorithms, support vector
machines and random forest) to predict the disintegration
time from ultrasonic measurements and several other tablet
properties (tablet diameter, thickness, weight, porosity and
breaking force) as well as process parameters (compression
force and tablet compaction speed). The use of such statistical
models may provide high correlation results, but one has to be
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Fig. 10 Apparatus to measure the
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Fig. 9 An apparatus to determine
water penetration, water up-take
and swelling of a tablet simulta-
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careful when training such models to avoid overfitting and to
assess generalisability. Moreover, statistical models do not re-
flect physical properties of the powder compact and thus no
fundamental insights about disintegration phenomena can be
gained from such models. However, the use of the ultrasound
technique provides some very interesting insights into the in-
ternal structure of tablets and can be used as a very powerful
sensor for in-die measurements during compaction process
development [136, 137].
A promising new technique to measure tablet disintegra-
tion is terahertz pulsed imaging (TPI). Most pharmaceutical
excipients are transparent to terahertz radiation (far-infrared
and sub-millimetre regime of the electromagnetic spectrum).
In TPI short pulses of this radiation are focused on the dosage
form of interest and the reflected echoes are recorded as a
function of their time-of-flight, much like ultrasound or radar
experiments [138]. Given the transparency of the tablet ma-
trix to terahertz radiation information from both surface and
internal structure of the dosage form can be measured in the
same experiment. The terahertz pulse can propagate through
the entire dosage form and reflections will be detected at every
interface where the refractive index of themedium is changing
such as internal cracks or the liquid front of penetrating liquid
into the tablet [139, 140]. This principle enables the monitor-
ing of the swelling and the liquid ingress as shown in Fig. 12
[77]. Yassin et al. [77] demonstrated that using this technique
it is possible to analyse liquid ingress and tablet swelling quan-
titatively. In addition, it is possible to detect cracks that can
form in some matrices due to the strain exerted by the hydra-
tion. Given the measurements are fast (acquisition rates of less
than 10 ms have previously been reported [141]) the method
is very well suited to investigate the disintegration of
immediate-release tablets.
Using the TPI method the effect of porosity and water
temperature on the disintegration was investigated in detail.
Liquid penetration and swelling was consistently faster at 37
°C compared to 20 °C [77]. The rates of swelling and wicking
were found to correlate with the porosity of the tablet and
could be described by a simple Darcy flow model (Fig. 13).
In a further study the effect of different binders, lubricants
and disintegrants was studied [142]. Lubricants are highly
hydrophobic materials, which significantly affect the wettabil-
ity of the porous matrix. Therefore, a lubricant is expected to
retard water penetration and thus the onset of disintegration
and dissolution [143, 144]. The mass fraction of the lubricant
is a critical factor as a minimum amount is required to cover
the surface of the particles and thus to fully exploit the func-
tionality of the lubricant [145, 146]. Yassin et al. concluded
that in the samples containing a lubricant the hydrationmech-
anism was dominated by anomalous mass transport (m ≈ 1 in
Eq. 4 for all three tested disintegrants (CCS, XPVP and SSG).
Given that anomalous transport processes result in inconsis-
tent hydration and disintegration kinetics, and thus increases
batch variability, this regime is not an ideal hydration mech-
anism for tablet disintegration. The study further revealed
that there is a critical concentration of binder for a tablet
formulation which will change the tablet properties and dom-
inate both the hydration and disintegration kinetics. However,
more work is required to understand the relation of lubricant
and binder concentration to tablet disintegration kinetics in
more detail.
The studies employing MRI and TPI primarily focused on
the initial phase of tablet disintegration, i.e. liquid penetration,
swelling and strain recovery, whereas the actual derupture of
particle-particle bonds and the further detaching of particles
from the tablet surface was not studied. Several research
groups determined the particle size distribution of the de-
tached particles directly. Shotton and Leonard [99, 100] used
a combination of a wet sieving technique and a Coulter
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Fig. 11 Quantitative analysis of tablet disintegration by MRI. (a) shows the
MRI data, which is binarised using a threshold image intensity. Subsequently
the edges are detected as depicted in (b), which is used for the calculation of
the fractal dimension. This procedure was applied on MRI measurements of
tablets with different disintegrants and analysed as a function of time as
depicted in (c). SSG I: sodium starch glycolate (Explotab); SSG II: sodium
starch glycolate (Primojel); PP I: polacrilin potassiumPolacrilin potassium
(Amberlite IRP88); PP II: polacrilin potassium (Kyron T-314); XPVP:
crospovidone (Polyplasdone XL), CCS: croscarmellose sodium (Ac-Di-Sol);
DCP: dibasic calcium phosphateDibasic calcium phosphate (Di-Cafos C92-
14) (modified from [131]).
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Counter to investigate the impact of intra- and extra-granular
incorporation of the disintegrant. They concluded that intra-
granular incorporation leads to smaller mean particle size,
whereas the disintegration time was longer. In general, a
smaller particle size causes a faster dissolution (see Eq. 13)
which was investigated by employing focused beam reflec-
tancemeasurements (FBRM) [147, 148] Focused beam reflec-
tance measurements and dynamic laser diffraction [149–151].
Several other studies used video imaging to count the number
of detached particles and to measure their size [20, 43, 152,
153]. Quodbach et al. [154] measured changes in particle size
during the disintegration of tablets using modified spatial fil-
tering velocimetry (Fig. 14). The detected particle size varied
highly between the beginning and the end of the disintegra-
tion process and also between different disintegrants. They
evinced that a further disintegration of particles occurs after
break up of the tablet core, which was also indicated by Zhao
et al. [151] using laser diffraction.
As highlighted in the previous section, the bioavailability of
the dosage form can be significantly influenced by the GI
environment. Several research groups investigated regional
differences in the GI to gain more knowledge about the influ-
ence of theGI environment, as well as more predictable in-vitro
in-vivo correlations [155]. The standard non-invasive methods
are γ -scintigraphy labelled with γ -emitting radioisotopes
[156, 157] or the visualisation of X-ray dense drug dosage
forms by repetitive X-rays [158, 159]. However, the applica-
tion of ionising radiation to humans is mostly restricted by
national laws on radiation protection and therefore, there
was the need to find alternative methods like biomagnetic
techniques. Magnetic sensors used for such investigations typ-
ically employ induction coils to measure biomagnetic fields
resulting from ferromagnetic sources in response to an applied
magnetic field. Thus, the samples must be labelled by mag-
netic materials, which is achieved by the incorporation of
powdered ferromagnetic substances (e.g. iron oxide) into the
dosage form. The technique of magnetic marker monitoring
combined with a very sensitive magnetic detector system, i.e.
superconducting quantum interference devices (SQUIDs), has
been used to record extremely sensitive magnetic fields with a
high temporal and spatial resolution. The strength, the three
dimensional localisation and orientation of the magnetic
0 s
48 s
Time delay (mm)
T
H
z
 f
ie
ld
 (
a
.u
.)
THz beam
WaterFlow cell
Tablet
front face 
Water
front 
Tablet
back face
Tablet back face Water front Tablet front face 
T
a
b
le
t
Fig. 12 Schematic of the experimental setup for the in-situ monitoring of the disintegration process by TPI and the deconvolved time-domain terahertz
waveforms (each line is offset by 0.01 a.u.). The terahertz waveforms shows the hydration of a pharmaceutical tablet consisting of 44% lactose anhydrous
(Tablettose 100, Meggle, Wasserburg, Germany), 30% MCC (PH102, FMC Biopolymers, Philadelphia, USA), 20% paracetamol, 5% CCS, 1% magnesium
stearate (MgSt) with 10% porosity.
5%20%
0 200 400 600 800 1000
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
Time (s)
P
e
n
e
tr
a
ti
o
n
 d
e
p
th
 (
m
m
)
Fig. 13 Disintegration kinetics quantified from TPI measurements of tablet
samples containing MCC, lactose, MgSt and CCS with different porosities
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source can be reconstructed from these measurements as a
function of time [160–162]. SQUIDs have been employed
for the in-vivo characterisation of the oesophageal transit, the
gastric and the intestinal behaviour of capsules [163, 164] and
tablets [161]. These studies showed that the in vivo disintegra-
tion of capsules in the stomach correlates very well with the
disintegration behaviour measured in-vitro [164]. However,
they further observed in several cases in different volunteers
that a capsule disintegrated in the small intestine and not in
the stomach as intended. In these cases the gastric residence
times were very short (< 3 min) and in one case a capsule
remained only for 15 s in the stomach.
Similar studies were performed by applying multisensor
alternate current biosusceptometry (ACB) to analyse the in-
vitro and in-vivo disintegration performance of magnetic tablets
in the human colon under normal physiological conditions
[165]. These measurements enabled the quantification of
the in-vivo performance by the gastric residence time, small
intestinal transit time, orocaecal transit time and the disinte-
gration time of magnetic formulations in the human gastroin-
testinal tract [165–167]. Cora et al. [168] further estimated
disintegration properties as well as the kinetics of disintegra-
tion process for different compression forces combining ACB,
water uptake and disintegration force measurements.
DRUG RELEASE KINETICS
Traditionally the key parameter to assess the performance of
a drug is to study the dissolution kinetics. As discussed
above, dissolution might occur simultaneously with disinte-
gration, though in the majority of cases one refers to the
dissolution afterthe disintegration. However, disintegration
and dissolution are interlinked and both processes have to
be considered when one assesses and further wants to im-
prove drug performance. Optimising the drug performance
by modifying the disintegration processes is specifically im-
portant for the increasing number of poorly-soluble drug
candidates, where dissolution is mainly the rate-limiting step
in drug absorption [169, 170]. This section focuses on results
from dissolution studies related to immediate-release tablets,
which are readily impacted by disintegration.
Traditional dissolution testing cannot be used to gain
insights about the early dissolution events acting in par-
allel to the disintegration as these methods suffer from
delayed response. The most promising technique to study
early dissolution is ultra-violet (UV) imaging providing
temporarily and spatially resolved absorbance maps.
Bøtker et al. [171] combined UV imaging, Raman spec-
troscopy and a channel flow cell method to study the
dissolution of amlodipine (Fig. 15). The authors demon-
strated that the dissolution of amlodipine besylate was
faster from the amorphous form than from the crystalline
forms. It is well known in pharmaceutical sciences that
the dissolution rate can be optimised by changing the
solid-state properties of the drug. This includes the use
of high-energy solid forms (e.g., amorphous systems), solid
dispersions or different polymorphs [172]. These ap-
proaches often result in metastable or even unstable
forms of the API, which might convert to a thermody-
namically more stable form [173] during disintegration.
Therefore, it is of great importance to better understand
the affect of a dissolution medium on the solid-state prop-
erties of the drug [174–176]. Østergaard et al. [177] ap-
plied simultaneously UV imaging with in-situ Raman
spectroscopy for the characterisation of drug dissolution
and solid state transformation during dissolution. They
demonstrated that sodium naproxen (Fig. 16) converted
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Fig. 14 Particle size of
disintegrated particles as a function
of time measured by modified
spatial filtering velocimetry. Left
column is the data of SSG (Primojel,
DMV-Fronterra Excipients, Goch,
Germany) and the right one is the
data of PP (AmberliteIRP88, Rohm
and Haas France SAS, Chauny,
France). (a) and (b) show particle
size distributions (contour plots) of
disintegrating tablets. The rows he
colour codes are the relative per-
centage of a given particle size. The
particle size developing over time is
depicted in (c) and (d) for SSG and
PP, respectively (modified from
[154]).
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to the more stable forms, i.e. naproxen monohydrate,
within 5 min.
To date research focused on the in-situ analysis of
modified-release tablets, where non-destructive methods
including near-infrared (NIR) Near-infrared spectroscopy
[7, 178], Raman spectroscopy [171, 177, 179], UV im-
aging [171, 177, 180, 181], infrared imaging [178,
182–184] and MRI [124, 185, 186] have been used very
successfully. However, there is still a lack of understand-
ing immediate-release tablets and solid state transforma-
tions occurring when the dissolution medium comes in
contact with liquid.
MODELLING OF DISINTEGRATION AND
DISSOLUTION
The last sections highlight that significant progress was made
experimentally in recent years to measure and better under-
stand disintegration phenomena. In order to transform the
design of solid dosage forms from an empirical art to a rational
science it is essential to quantitatively describe the relationship
between structure, formulation and disintegration behaviour.
Mathematical models that accurately describe the physics of
the process are required to reliably predict tablet disintegra-
tion, dissolution and eventually the drug release profile. In
order to achieve this the models not only have to describe
liquid ingress, swelling, strain recovery, dissolution as well as
disruption of particle-particle bonds (Fig. 3) with sufficient
accuracy but also how these processes are linked and interde-
pendent. This is clearly a highly complex problem. Although
several studies presented models for each mechanism inde-
pendently, to the authors’ best knowledge, there is no single
model combining the different phenomena.
Liquid Penetration and Swelling
The transport kinetics of a range of formulations and physical
properties were modelled by Yassin et al. [77] using a simple
power law. This semi-empirical model was previously used to
study drug release kinetics [187–190] and can be expressed by
y ¼ ktm; ð4Þ
where k is a constant related to the structural and geometric
characteristics of the tablet and the exponent m is related to
the mass transport mechanism [187]. In the study by Yassin
et al. the parameters k and m were fitted to experimentally
acquired time-resolved liquid penetration data as measured
by TPI (see Fig. 13 for the data). Based on the value of the
exponent m the mass transport mechanism is assumed to be
dominated by a pressure gradient (typically referred to as
Darcy flow), by an activity gradient (case II relaxation) or
can be regarded as a combination of both (anomalous diffu-
sion) [77]. Figure 17 shows the results of such analysis for a
range of porosities in MCC based tablets. As expected, Darcy
flow characteristics are dominating at higher porosity as faster
liquid penetration can take place given the larger amount of
available pore space.
The experimental results highlight that under certain con-
ditions the movement of the liquid front in a porous tablet
with porosity ε can be described by Darcy’s law (Eq. 18)
[87]. An equation for the liquid penetration can be analytical-
ly derived by neglecting the effect of gravity and using the
Young-Laplace equation (Eq. 16) for the capillary pressure:
L ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
εK
4γcos θ
ηRc;0
t
s
: ð5Þ
As a note, the capillary radius Rc,0 is the pore radius, which
is seen by the liquid meniscus. If the liquid penetration is
driven by capillary action, it can also be modelled using the
Hagen-Poiseuille (Eq. 15) and Young-Laplace (Eq. 16) equa-
tions. Combining both equation gives an expression for the
liquid front L in the porous medium, which is known as the
Washburn equation [191]:
L ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Re
γcos θ
2η
t
s
: ð6Þ
Here Re= Rh,0
2 /Rc,0 (Rh,0 is the hydrodynamic radius) is the
mean effective pore radius. The Washburn euqation is com-
monly used across a range of scientific and engineering disci-
plines to study penetration kinetics in porous media. One of
the first applications of the Washburn equation in the phar-
maceutical science was presented by Nogami, Hasegawa and
Miyamoto [36]. They slightly adapted Eq. 6 to predict the
water penetration time in aspirin tablets with starch as a
Fig. 15 Dissolution rates of amorphous amlodipine besylate (▼),
amlodipine besylate dihydrate (•) and amlodipine free base (∘) as a function
of time using UV imaging (modified from [171]).
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disintegrant, which showed a good correlation with the mea-
sured disintegration time.
Both theWashburn equation andDarcy’s law approach con-
clude a square root dependence of the liquid penetration on
time. Comparing the power law (Eq. 4) with Darcy’s law
(Eq. 5) and the Washburn equation (Eq. 6) shows that both
models predict the liquid penetration in powder compacts to
follow the behaviour of m= 0.5 in Eq. 4. It further shows that
the constant k in this expression is related to themicrostructure of
the matrix (porosity, pore radius, permeability), fluid (viscosity,
surface tension) and fluid/matrix (contact angle) properties.
However, these simple models were developed for rigid
systems and do not account for any swelling of the matrix
during hydration. As discussed in the previous sections, swell-
ing is not only very common for pharmaceutical formulations
but it is often essential for successful disintegration to take
place. Swelling results in a dynamic change of the intrinsic
permeability, porosity and pore radius. It is therefore very
useful in the pharmaceutical context to consider models that
have been developed specifically to describe the hydration/
dehydration of porous food materials [192] and wicking in
paper-like porous media [193–195].
Schuchardt and Berg [196] adapted the Washburn
equation by assuming a linear decrease with time of the
pore radius in the wetted area of a porous medium (a
composite of cellulose and superabsorbent fibres). They
considered Rh as the time-dependent effective hydrody-
namic radius behind the advancing liquid front. Rh is thus
defined as a linear function of time (Rh = Rc,0 − a ⋅ t),
where a is the rate of pore radius constriction. The mod-
ified Washburn equation is thus expressed by
L ¼
Rc;0cos θ
2η
 1.2
t−
a
Rc;0
t2 þ
a2
3R2c;0
t3
 !1.2
: ð7Þ
Following the approach by Schuchard and Berg, Masoodi
et al. [194] developed amodel based onDarcy’s law in order to
consider the swelling of the particles within the solid matrix
and thus the constriction of the pores. They derived the fol-
lowing equation for the liquid penetration:
L ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2P c
ε0η
Zt
0
K t
0
 
dt
0
vuuut : ð8Þ
a b
c
Fig. 16 Studying the fast
dissolution process of sodium
naproxen in 0.1 M HCl by UV
imaging and in-situ Raman
spectropscopy. (a) UV absorbance
maps for selected time points. Red
colour indicates high absorbance
and the contours represent
isoabsorbance lines. (b) The
dissolution rate and cumulative
amount of dissolved naproxen. (c)
Fractional sodium naproxen/
naproxen form conversion as a
function of time. The fractions of
intermediate solid form 1, interme-
diate solid form 2, intermediate
solid form 3, and naproxen are
represented as (▼), (•), (∘) and (△),
respectively (modified from [177]).
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Fig. 17 Exponentm (see Eq. 4) estimated from TPI measurements depend-
ing on porosity. The liquid penetration of the respective samples are shown in
Fig. 13. Samples contain MCC, CCS, lactose andMgSt. Tablets were hydrated
at 20°C. Error bars represent the standard deviation.
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This model allows to analyse the time-dependent perme-
ability, porosity and pore size and thus it provides an insight
into themicrostructural changes during the hydration of swell-
ing porous media. However, it is important to point out that
these models describe the swelling process only during the
transient liquid penetration and do not provide any details
about the subsequent swelling once the powder compact is
fully hydrated.
Experimental data of samples that contain a large amount
of crosslinked polymer or microcrystalline polymer indicates
that typically two phases of swelling are taking place succes-
sively in such materials: initial rapid swelling due to liquid
penetration and secondary swelling due to the disentangle-
ment and diffusion of the polymer macromolecules into the
hydrating solution [45, 46]. The second, much slower, phase
of swelling appears to be asymptotic in nature and can be
modelled using the Schott model [45, 46]. The original
Schott model was developed to describe the water uptake in
semicrystalline polymers such as gelatine and cellulose
expressed as a mass uptake in grams of absorbed solution
per grams of solid matrix. It was modified for the case of
one-dimensional swelling Δδ (in units of m):
Δδ ¼
t
Aþ
1
δ∞−δ0
t
: ð9Þ
A (swelling) is a material constant that can be determined
experimentally by linear regression. δ0 and δ∞ represents the
initial tablet thickness and the final thickness of the tablet after
swelling, respectively. It was shown that 1/A is related to the
initial swelling rate of the tablet, which could be further used
to model the swelling of single particles and its impact on the
pore radius reduction during the initial fast hydration process.
The combination of the Schott model (Eq. 9) and themeth-
od based on Darcy’s law (Eq. 8) facilitates the analysis of mi-
crostructural changes during the liquid penetration, such as
pore radius, porosity and permeability as a function of time
(Fig. 18). As the data in the figure shows, significant changes of
the porosity, pore radius and permeability can be observed for
plain MCC tablets with two different initial porosities (ε0=
0.10 and ε0= 0.15). The swelling of individual MCC particles
causes a decrease of the average pore radius, which reduces
the porosity of the powder compact as time increases. Since
the permeability is also a function of the pore radius, it de-
creases over time as well. These simulations clearly emphasise
the complex interplay between the different microstructural
properties of a tablet, which cannot be examined in such detail
on the basis of experimental data only. However, newly de-
veloped models have to be validated by experimental data on
the basis of characteristic measurable disintegration phenom-
ena, i.e., liquid penetration and swelling. Therefore, it is only
through a combination of modelling approaches and in-situ
monitoring that fundamental insights of the disintegration
process can be gained.
Using a different approach, swelling and the resultant detach-
ment of particles was modelled by Caramella et al. [197] by
considering the disintegration mechanism as physically analo-
gous to the phenomenon of nucleation and growth [40, 198].
Their model treats the progressive tablet expansion alongside an
associated layer detachment process (Fig. 19). A similar model
was already introduced in the 60s by Nogami, Hasegawa and
Miyamoto [36] to study the liquid penetration into aspirin tab-
lets. In themodels of both groups the assumption ismade that the
disintegration of particles occurs only in layers parallel to the
surface of the largest area of the tablet (i.e. in axial direction). In
the model from Caramella et al. the normalised disintegration
force as a function of time is given by the equation
F
F∞
¼ 1−exp −atmð Þ; ð10Þ
with a as the expansion rate and where m is representing the
mechanism of the disintegration. Caramella et al. [197] extracted
and compared these parameters to differentiate between
interface-controlled (i.e. interfacial detachment of particles from
the surface) and diffusion-controlled (i.e. local diffusion of parti-
cles once they have been detached) disintegration. Peppas and
Colombo [40] later expanded this analysis and provided a mod-
el which considers fluid mechanical phenomena, the changes in
pore structure during the initial water uptake as well as the
swelling of the disintegrant:
F ¼ C0 þ C dw
1
.
2
þ C cw ð11Þ
w is the amount of water entering the tablet expressed as
grams of water per grams of solid matrix. C0 describes the
initial stresses of the tablet and the potential change of stresses
when water fills the pores. Cc and Cd are indicative for the
relative importance of the convective and diffusive portion of
the disintegration phenomenon. The model was verified using
the apparatus presented in Fig. 10 and it was shown that the
force is a linear function of the absorbed amount of water until
the swelling becomes active and causes a change of the kinet-
ics, i.e. the force is then a function of the square root of the
water quantity.
The models by Caramella et al. were a first step towards
describing the interruption of particle-particle bonds. In order
to model the rupture of the inter-particle bonds, one needs to
consider the formation of cracks within the tablet [142].
Cracks may propagate in the direction of fluid movement
through the tablet until the critical crack length is reached
where the dosage form fractures. This process is conceptually
similar to the more well understood mechanisms in other
fields of wet granular matter (pendular, funicular, capillary
and slurry states). Therefore, models developed in these fields
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[199–201] could be used in future to quantitatively describe
the last phase of the disintegration process and to determine
the critical stage when the liquid bridges rupture and the
tablet completely disintegrates.
Drug Release Kinetics
The history of dissolution research started in the 19th century
when Noyes and Whitney conducted the first dissolution ex-
periments [202]. The authors concluded that the rate at which
a solid dosage form dissolves is proportional to the difference
between the instantaneous concentration ct at time t and the
concentration of the saturated solution cS . This statement can
be expressed as
dct
dt
¼ k cS−ctð Þ: ð12Þ
Nernst [203] and Brunner [204] carried out further exper-
imental studies and addressed the physical meaning of the
constant k as defined by Noyes and Whitney. They applied
the diffusion layer concept and Fick’s first law yielding the
Nernst-Brunner equation:
dct
dt
¼
DS
V δ
cS−ctð Þ: ð13Þ
D is the diffusion coefficient, S the surface area available for
diffusion/dissolution, δ is the thickness of the diffusion layer
Fig. 19 Modelling the detachment of particles during disintegraton. (a) Layer
detachment and progressive tablet expansion. (b) Normalised disintegration
(swelling) force depending on time. Curve 1 indicated the results for a tablet
consisting of CaHP04 ⋅ 2H2O with 1 wt% polyplasdone XL. Curve 2 cor-
responds toCaHP04 ⋅ 2H2Owith 20 wt% polyplasdone XL (modified from
[197]).
ε/
ε 
 (
−
)
0
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ε
Fig. 18 Simulation results from modelling the liquid penetration in swelling
MCC tablets for two different tablet properties (solid line corresponds to
ε0=0.10 and dashed line corresponds to ε0=0.15). R0: initial pore radius;
Rc: time-dependent pore radius; ε0: initial porosity; ε time-dependent poros-
ity. A modified Carman-Kozeny (see Eq. (5) in [208]) was used to model the
permeability as function of porosity.
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and V is the volume of the dissolution medium. From looking
at the Nernst-Brunner equation, it is immediately obvious that
the kinetics of drug dissolution is affected by intrinsic and
extrinsic factors. The intrinsic properties of a drug substance
that may influence the dissolution include crystallinity, poly-
morphism, hydration, particle size and particle solid surface.
The total surface area of the sample exposed in the solvent is
one of the main aspects that influences the dissolution rate. In
fact the dissolution process can be accelerated by increasing
surface area and decreasing the particle size. Furthermore,
hydrodynamics and composition of the dissolution medium
(e.g. pH, temperature, presence of solubilising agents) are ex-
trinsic factors which affect the kinetics of dissolution. The
Noyes-Whitney and Nernst-Brunner equations provided the
basis for understanding drug release kinetics; even though
they do not address all mechanisms involved in the drug re-
lease process. Wilson et al. [153] used a slightly modified form
of the Nernst-Brunner equation and combined it with a pop-
ulation balance model to simulate the dissolution profile by
considering the erosion of a tablet. The authors considered
disintegration and dissolution in terms of reaction rates en-
abling the combination of both processes.
As summarised by Siepmann and Siepmann [189], besides
the dissolution process itself the drug release of oral dosage
forms includes the diffusion of water into the system, drug
diffusion out of the device, polymer swelling, matrix former
erosion, osmotic effects and various other phenomena. These
processes occur in sequence but differ in terms of action time.
Although drug diffusion is the predominant step in the major-
ity of the cases, polymer swelling or polymer degradation/
matrix erosion need to be considered to fully understand the
drug release kinetics.
The dissolution behaviour of controlled-release dosage
forms was studied in much more detail by developing mathe-
matical models and applying a range of non-destructive
methods. A number of studies described the drug release ki-
netics by combining experimental data and theoretical models
[188, 205]. It was shown that the rate of diffusion into and out
of a tablet can be described by a semi-empirical equation,
i.e. the power law as depicted in Eq. 4. k is again a constant
related to the structural and geometric characteristics of the
tablet; m is the release exponent indicating the mechanism of
drug release. Another semi-empirical model is the Peppas-
Sahlin equation [206] given as
M t
M∞
¼ k1t
m þ k2t
2m; ð14Þ
with the constants k1, k2 and m. Mt and M∞ are the
absolute cumulative amount of drug released at time t
and infinite time, respectively. Similar to the discussion
above for porous systems, both the power law and the
Peppas-Sahlin equation are used to differentiate between,
here, Fickian diffusion and case II relaxation; Fickian
transport relies on a concentration gradient and case II
transport on an activity gradient. In analogy to our dis-
cussion above the power law can also be used to describe
an anomalous diffusion containing both Fickian and case
II characteristics. Siepmann and Siepmann [189, 190]
described models for a broad range of controlled-release
devices including reservoir and matrix systems, which may
or may not exhibit an initial excess of drug, and that are
valid for a range of geometries: slabs, spheres and cylin-
ders. However, the majority of studies have not consid-
ered the impact of the dosage form’s microstructure,
which is particularly important for immediate-release for-
mulations. Only the combination of models describing the
liquid penetration, swelling, the formation of cracks and
the break up of the tablet as well as the dissolution of the
disintegrated particles will lead to a sound understanding
of the disintegration and dissolution processes of
immediate-release tablets.
CONCLUSIONS
For more than 15 years there has been a concerted effort in
the pharmaceutical community to improve the quality and
consistency of pharmaceutical products by introducing a par-
adigm shift to how we innovate higher quality medicines. This
has included the development of concepts such as QbD and
process analytical technology (PAT) initiatives that aim to ac-
tively encourage in an in-depth understanding of processes
and product characteristics that could be used to implement
suitable control strategies to pharmaceutical processing.
Significant progress has been achieved and advanced analyt-
ical methods are now routinely deployed to test chemical and
physical quality attributes throughout drug product develop-
ment and manufacturing.
However, not all areas of process understanding and
quality testing have been equally transformed by this de-
velopment. Even though there is clearly a longstanding
interest in improving the rational understanding of the
complex disintegration process that is well documented
in the literature and innovative methodologies have been
proposed to better measure the phenomena involved
there has been no breakthrough yet in developing robust
quantitative models of the process that could be used for
the rational design of disintegrating dosage forms.
We believe that one of the factors that presently limits
the development of a better understanding of the funda-
mental importance of disintegration can be found in the
anachronistic disintegration test prescribed by the phar-
macopoeia. Not only does the test fail to provide any
insight into the physico-chemical changes that govern dis-
integration but, by defining the disintegration time as the
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time after which the last of six tablets fully disintegrates,
the test result makes it hard, if not impossible, to resolve
the subtle variations in microstructure that are critical for
the process. The test was developed more than 80 years
ago and the testing protocol has not changed very much
over the years yet a large range of novel rapidly
disintegrating formulations, dosage forms and new excip-
ients have been developed in the interim and with this
development the quality control requirements have
changed. Whilst the disintegration test has served an ex-
cellent purpose since its inception it had the unfortunate
side effect that too many pharmaceutical scientists now
habitually assume that the disintegration test is a suitable
test to investigate disintegration. It is important to high-
light that this is not the case – it is a very good test to
document compliance with a particular validation proto-
col required by the pharmacopoeia but it was never de-
signed to help with the understanding of the complex
process itself.
Besides the analytical testing procedure itself we have iden-
tified a range of scientific challenges that need to be addressed
before mathematical models will be available that can be used
as confidently to predict disintegration as it is possible for
dissolution today. The role of the microstructure of the porous
matrix on the disintegration mechanism and kinetics is clear
and it is absolutely clear that subtle variations in processing
parameters result in significant changes for the disintegration
process. A detailed understanding of the interplay between
process parameters, microstructure and disintegration behav-
iour will be critical for high quality immediate-release prod-
ucts manufactured by continuous processing with active feed-
back loops controlling the process.
Overall, the design of immediate-release dosage forms will
greatly benefit from quantitative physical models of disinte-
gration and we hope this review will stimulate fruitful discus-
sion and encourage further work in this area to achieve this
aim in the near future.
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APPENDIX A: LIQUID PENETRATION
IN A POROUS TABLET
The liquid penetration in highly porous immediate-release
tablets is driven by capillary forces. Therefore, the pore space
is approximated as a bundle of capillary tubes of varying di-
ameter. Based on this assumption liquid ingress can be
described by a Hagen-Poiseuille motion of liquid in the set
of parallel capillary tubes. The volumetric flow rate Qi in a
tube i (i∈ℕ, i ≤ N with N as the total number of cylindrical
tubes) with uniform radius Rh,i (also known as the hydrody-
namic radius) can be expressed by
Q i¼ −
πR4h;i
8η
dP
dx
					
x¼Li
¼ −
πR4h;i
8η
ΔP i
Li
¼ −
XM
j¼1
πω jR
4
h; j
.
L jΔP j
8Aη
ð15Þ
where Li is the length of the liquid front in tube i at
time t and η is the viscosity of the liquid. ΔP is the total
effective pressure which is acting to force the liquid along
the capillary and consists of atmospheric pressure, hydro-
static pressure and capillary pressure. We could divide
the pores in M pore size classes, where ωj represents
the number of pores in the jth pore size class (j∈ℕ, j ≤
M) with radius Rh,j and volumetric flow rate Qj. The total
volumetric flux q = Q/A (with A as the cross-section area)
is then given by
q ¼
XM
j¼1
ω jQ j
A
:
Using the Young-Laplace equation for the capillary pres-
sure
ΔP j ¼
2γcos θ
Rc; j
; ð16Þ
where γ is the surface tension, θ is the contact angle, Rc,j is
the capillary radius and neglecting the atmospheric pressure
and hydrostatic pressure, yields
q ¼ −
γcos θ
4η
XM
j¼1
πω j
A
R4h; j
Rc; j
1
L j
We further introduce the tortuosity factor τ to account for
the lengthened distance of pores. τ is the ratio of the actual
path along the pore to the straight flow path. The volume
fraction of pores (approximated as the area fraction) is consid-
ered by
Δβ j≈
ω jπR
2
h; j
A
:
The volumetric flux q of the fluid can now be written as
q ¼ −
1
4τ
γ
η
cos θ
XM
j¼1
Δβ j
R2h; j
Rc; j
1
L j
: ð17Þ
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APPENDIX B: DARCY’S LAW
Darcy’s law can be expressed as
q ¼ −
K
η
dP
dx
				
x¼L
¼ −
K
η
ΔP
L
; ð18Þ
with K as the intrinsic permeability. Comparing Eqs. 17
and 18,
q ¼ −
K
η
ΔP
L
¼ −
1
8τ
XM
j¼1
Δβ jR
2
h; j
ΔP j
L j
¼ −
1
8τ
XM
j¼1
Δ β jR
2
h; j
ΔP
L
;
and using ΔP ¼ 1=M ∑
M
j¼1
ΔP j and L ¼ 1=M ∑
M
j¼1
L j gives an
expression for the intrinsic permeability:
K ¼
1
8τ
XM
j¼1
Δβ jR
2
h; j : ð19Þ
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